Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLA vs CLA for H. pylori Eradication
NCT02726269Phase 3Completed
- Sponsor
- Asofarma
- Start
- Jun 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of levofloxacin in Helicobacter pylori infection (2 arms), sponsored by Asofarma. Primary endpoint: Helicobacter Pylori eradication rate. Started Jun 2012; status: completed.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02726269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726269.